UCHL5 and cancer: A recent article found that PTIR1 binds to the C-terminal of UCHL5 and activates its ubiquitination function, thereby inhibiting immune proteasome activity and limiting the processing and presentation of neoantigens, then preventing T cells from recognizing and attacking cancer [46].